HF
BYAH

HRT Financial’s Park Ha Biological Technology Co BYAH Stock Holding History

HRT Financial’s Portfolio BYAH Stock Details BYAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-37
Closed -$195K – 3703
2025
Q1 		$195K Sell
37
-17
-31% -$46.3K ﹤0.01% 2039
2024
Q4 		$134K Buy
+54
New +$110K ﹤0.01% 2007

Other funds holding BYAH

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $26.8B AUM 33.07% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

HRT Financial's BYAH Position: Q2 2025 in Review

HRT Financial sold out of Park Ha Biological Technology Co (BYAH) in Q2 2025, closing a stake of 37 shares — an estimated $195K sold.

HRT Financial first reported a position in BYAH in Q4 2024 and held it in 2 quarters. The position peaked at $195K in Q1 2025. 12 funds tracked by Wall St. Rank hold BYAH as of Q2 2025.

  • HRT Financial reported no remaining Park Ha Biological Technology Co position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 37 Park Ha Biological Technology Co shares in Q2 2025, an estimated $195K.
  • HRT Financial first reported a position in Park Ha Biological Technology Co in Q4 2024 and held it in 2 quarters.
  • HRT Financial's Park Ha Biological Technology Co position peaked at $195K in Q1 2025.
  • 12 funds tracked by Wall St. Rank held Park Ha Biological Technology Co as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.